Back
PT Bank Mandiri (Persero) Tbk Vs. Denali Therapeutics Industry Stock Comparison
Buy
58
PPERF
PT Bank Mandiri (Persero) Tbk
Last Price:
0.47
Seasonality Move:
7.58%
Buy
56
DNLI
Denali Therapeutics
Last Price:
30.74
Seasonality Move:
17.79%
Buy
58
PT Bank Mandiri (Persero) Tbk (PPERF)
is a Buy
Is PT Bank Mandiri (Persero) Tbk a Buy, Sell or Hold?
- The current PT Bank Mandiri (Persero) Tbk [PPERF] share price is $0.47. The Score for PPERF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- PPERF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $30.68. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PPERF Stock Price Chart
What is PT Bank Mandiri (Persero) Tbk's stock price today?
-
The PT Bank Mandiri (Persero) Tbk share price today is $0.47
The current trend is moderately bearish and PPERF is experiencing slight buying pressure.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $30.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing slight buying pressure.
PPERF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 51.07 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.45 - 0.49) | Buy |
Bollinger Bands (100): | (0.38 - 0.46) | Buy |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.67 | Buy |
Relative Strength Index (14 RSI): | 77.92 | Buy |
Chaikin Money Flow: | 34344 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.24 - 27.72) | Buy |
Bollinger Bands (100): | (18.96 - 25.08) | Buy |
PPERF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.49 | Sell |
20-day SMA: | 0.48 | Sell |
50-day SMA: | 0.44 | Buy |
200-day SMA: | 0.42 | Buy |
8-day EMA: | 0.48 | Sell |
20-day EMA: | 0.48 | Sell |
50-day EMA: | 0.45 | Buy |
200-day EMA: | 0.41 | Buy |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28 | Buy |
20-day SMA: | 26.04 | Buy |
50-day SMA: | 24.18 | Buy |
200-day SMA: | 20.53 | Buy |
8-day EMA: | 28.54 | Buy |
20-day EMA: | 26.57 | Buy |
50-day EMA: | 24.56 | Buy |
200-day EMA: | 22.12 | Buy |
PT Bank Mandiri (Persero) Tbk Earnings Growth & PPERF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
PT Bank Mandiri (Persero) Tbk Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |